Latest Mass Tort News and Updates

Last week, parties involved in the talcum powder litigation submitted a Status Report and Proposed Joint Agenda for the status conference scheduled for today to review the progress…

Our drafted PI Demand Letter begins at the point of impact and ends with the medical chronology of treatment. It guides the adjuster through all that the claimant has lost as a result of the insured's negligence.

In PI matters, we are…

Purdue Pharma's former president and board chair of the company claimed that he, his family, and the company are not responsible for the opioid crisis throughout the United States.…

New Jersey’s Supreme Court has announced centralization of all Tasigna lawsuits across the country before Superior Court Judge Rachelle Harz in Bergen County for coordinated pretrial proceedings.

…

A petition to review a Zoloft birth defect case dismissed earlier when the plaintiffs’ causation expert was excluded by the trial court was denied by the Pennsylvania Supreme Court.…

C.R. Bard and its Davol, Inc. subsidiary have proposed that from over a thousand lawsuits faced by them, claims related to Bard Ventralight ST and Bard Ventralex mesh be the first to go before a jury later this year.

The company…

The official committee of talc claimants asked a New Jersey bankruptcy judge to dismiss Johnson & Johnson's (J&J) Chapter 11 case by stating that the proceeding is…

Johnson and Johnson's widely used and globally accepted Talc is facing allegations of causing Ovarian cancer when used perennially. Consecutively, six verdicts in favor of the plaintiffs have made the situation positive for the other filed…

The JPML is reviewing the motion filed with them to transfer and consolidate the "National Prescription Opiate Litigation" which was long due to handling the Opioid crisis sweeping across the nation. Opiate drug makers are also facing lawsuits by…

The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral…